In my two decades of working with cardiac technology, I have seen portable ECG monitors evolve from simple rhythm checkers into sophisticated diagnostic tools that fit in a shirt pocket. But here is the honest truth: the best device for a cardiologist doing a stress test is not the best device for a patient checking palpitations at home. And the device your neighbor swears by might be useless for your specific situation. Let me cut through the marketing noise and give you a practical comparison based on what I have seen in clinics, ambulances, and home care settings.
First, understand that all portable ECGs fall into three functional categories. The first is single-lead devices, which capture the basic electrical activity of the heart from one vector. These are excellent for detecting atrial fibrillation and premature beats. The second is multi-lead devices, typically 6 or 12 leads, which give a more complete picture of the heart's electrical axis and are better for ischemia detection. The third is patch or continuous monitors that record for days or weeks. For most home users, a single-lead device is sufficient, but if you have known coronary artery disease, you want nothing less than a 6-lead system.
Now, let me compare the three devices I recommend most often. The KardiaMobile 6L is my top pick for clinical accuracy at home. It uses two thumbs and a leg contact to produce a medical-grade 6-lead ECG in 30 seconds. The algorithm detects AFib, bradycardia, and tachycardia with FDA-cleared precision. The downside is that it requires a smartphone and has no screen of its own. The second option, the Eko DUO, is a hybrid that pairs an ECG with a digital stethoscope. This is a game-changer for patients with both rhythm issues and valve problems, but it costs nearly twice as much and has a steeper learning curve. The third is the Apple Watch Series 9, which I include reluctantly. Its single-lead ECG is decent for AFib detection, but it misses many arrhythmias and cannot be used for diagnostic confidence. However, for passive monitoring and fall detection in elderly patients, it has no equal.
What should you actually look for when buying? First, check the sampling rate. A device sampling at 300 Hz or higher captures more detail than one at 128 Hz. Second, look at the algorithm's validation studies, not just the marketing claims. The best devices have published data in peer-reviewed journals. Third, consider the form factor. If you have arthritis, a device requiring precise thumb placement will frustrate you. Fourth, battery life matters more than you think. A device that dies during a symptomatic episode is worse than no device at all. Finally, make sure the data export is compatible with your electronic health record or at least produces a PDF your doctor can actually read.
My closing advice is simple. Do not buy the cheapest device, and do not buy the most expensive one. Buy the one that fits your clinical need and your physical abilities. For the average person over 50 with palpitations, the KardiaMobile 6L is the sweet spot. For a patient with heart failure who needs daily trends, the Eko DUO is worth the investment. And for a family monitoring an aging parent, the Apple Watch provides convenience but not diagnostic certainty. Whichever you choose, remember that a portable ECG is a screening tool, not a replacement for a full 12-lead test. When in doubt, record a trace and send it to your cardiologist. That single habit has caught more arrhythmias than any other piece of technology I have ever recommended.